WallStreetZenWallStreetZen

NASDAQ: SYRE
Spyre Therapeutics Inc Stock Ownership - Who owns Spyre Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Spyre Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Cameron TurtleChief Executive Officer2024-02-15400$9.82
$3.93kBuy

1 of 1

SYRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SYRE insiders and whales buy or sell their stock.

SYRE Shareholders

What type of owners hold Spyre Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC39.56%14,301,760$471.82MInsider
Fmr LLC10.47%3,785,877$124.90MInstitution
Baker Bros Advisors LP8.56%3,094,590$102.09MInsider
Orbimed Advisors LLC7.83%2,829,748$93.35MInsider
Perceptive Advisors LLC7.21%2,606,679$85.99MInstitution
Vr Adviser LLC6.56%2,372,714$78.28MInstitution
Rtw Investments LP6.18%2,232,760$73.66MInstitution
Novartis Bioventures Ltd6.02%2,175,314$71.76MInsider
Deep Track Capital LP5.40%1,952,760$64.42MInstitution
Commodore Capital LP5.21%1,884,084$62.16MInstitution

1 of 3

SYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SYRE52.09%47.91%Net BuyingNet Buying
XNCR66.74%33.26%Net BuyingNet Selling
FDMT83.80%16.20%Net BuyingNet Selling
PHVS77.92%0.00%
DAWN54.70%45.30%Net BuyingNet Selling
View Top Biotech Stocks

Spyre Therapeutics Stock Ownership FAQ

Who owns Spyre Therapeutics?

Spyre Therapeutics (NASDAQ: SYRE) is owned by 77.48% institutional shareholders, 71.28% Spyre Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Spyre Therapeutics shareholder, owning 14.30M shares representing 39.56% of the company. Fairmount Funds Management LLC's Spyre Therapeutics shares are currently valued at $464.38M.

If you're new to stock investing, here's how to buy Spyre Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.